In a recent transaction, Arteris, Inc. (NASDAQ:AIP) Vice President and General Counsel Paul L. Alpern sold shares of the company’s stock for a total of approximately $81,512. The transactions occurred on April 1, 2024 and were reported in a Form 4 filing with the Securities and Exchange Commission.
Alpern sold a total of 11,250 shares of Arteris common stock. The sales were executed in multiple transactions at prices between $7.24 and $7.29 per share. This price range indicates that the executive received an average approximately between these prices for each share sold.
In addition to the sales, Alpern also performed options exercises on the same day. The options, which were converted into common stock, included 10,000 shares at a price of $0.56 per share, for a total of $5,600, and 1,250 shares at a price of $0.60 per share, for a total of $750 . It is worth noting that these options exercises are separate from selling trades and represent the cost of acquiring the shares rather than the proceeds of selling them.
Form 4 also contained a footnote indicating that the sales were made pursuant to a 10b5-1 trading plan adopted by Alpern on August 16, 2023. Such trading plans allow company insiders to establish transactions pre-planned at a time when they are not. in possession of material non-public information, which constitutes a defense against potential insider trading charges.
The statement also mentioned that the price reported for the larger sales transaction is a weighted average price. Alpern has agreed to provide, upon request, complete information regarding the number of shares sold at each separate price within the reported range.
Investors and followers of Arteris, Inc. may find this information relevant as it provides insight into the actions of key executives and their outlook on the value of the company’s stock. It is important to note that insider transactions can vary in motivation and may not always be indicative of the company’s future performance.
For more detailed information, interested parties can refer to the complete Form 4 available on the Securities and Exchange Commission website.
Insights on InvestingPro
As investors digest Arteris, Inc.’s recent insider transactions, it is useful to consider the company’s financial position and market performance. According to InvestingPro, Arteris boasts an impressive gross profit margin, which stands at a robust 90.54% for the trailing twelve months as of Q4 2023. This figure is a testament to the company’s ability to maintain profitability of its core operations , which could be an advantage. reassuring signal for investors worried about recent insider sales.
Additionally, Arteris has demonstrated strong market performance over the past year, with a one-year total price return of 67.85%. This indicates that despite any short-term fluctuations, the company’s shares have provided significant returns to shareholders over the long term. Additionally, Arteris has been trading at a high price-to-book multiple of 17.79, suggesting that investors are willing to pay a premium for the company’s assets over its book value.
An InvestingPro tip worth mentioning is that the company holds more cash than debt on its balance sheet, which provides a cushion against market volatility and financial uncertainties. This could be particularly reassuring given the insiderselling activity. Another tip from InvestingPro is that three analysts have revised their earnings upwards for the coming period, suggesting potential optimism about the company’s future financial performance.
Arteris’ next earnings date is set for May 7, 2024, and investors may want to keep an eye on this event for further clues about the company’s trajectory. For those looking for deeper analysis and additional insights, InvestingPro offers 6 more recommendations on Arteris, Inc., which can be accessed with a subscription. To get an extra benefit, use the coupon code PRONEWS24 to get an additional 10% discount on the annual or biennial Pro and Pro+ subscription.
This article was generated with the support of AI and reviewed by an editor. For further information please see our T&Cs.